Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · Real-Time Price · USD
1.090
-0.120 (-9.92%)
At close: Nov 16, 2026, 4:00 PM EST
1.110
+0.020 (1.83%)
Pre-market: Nov 17, 2026, 7:06 AM EST

Lisata Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
101625222050
Market Cap Growth
-48.58%-34.42%12.58%11.75%-60.48%81.39%
Enterprise Value
-273-3-11-32-55-50
Last Close Price
1.091.862.982.732.5312.62

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
98.2296.5125.02---
PB Ratio
1.541.120.850.460.300.55
P/TBV Ratio
-1.100.850.460.300.55

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
--0.010.010.010.01
Net Debt / Equity Ratio
-0.48-1.09-1.06-1.05-1.04-1.02
Net Debt / EBITDA Ratio
12.840.881.401.972.533.25
Net Debt / FCF Ratio
13.051.001.612.513.204.23
Asset Turnover
00.010.02---
Quick Ratio
13.855.425.837.6710.9621.00
Current Ratio
14.095.776.168.1811.2621.27
Return on Equity (ROE)
-5.64%-75.53%-51.77%-36.49%-68.50%-44.21%
Return on Assets (ROA)
-4.11%-43.15%-31.23%-25.16%-20.00%-27.30%
Return on Capital Employed (ROCE)
-3.50%-124.10%-76.20%-53.40%-40.80%-31.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-173.85%-101.09%-79.89%-93.79%-272.69%-54.59%
FCF Yield
-220.55%-97.38%-77.37%-90.15%-107.90%-44.33%
Buyback Yield / Dilution
-5.47%-4.30%-3.17%-55.85%-40.46%-258.29%
SEC Filings: 10-K · 10-Q